Related Experiment Video
Updated: Mar 18, 2026

Cell Type-specific Gene Expression Profiling in the Mouse Liver
Published on: September 17, 2019
Functional and cellular consequences of covalent target protein modification by furan in rat liver
Susanne Ramm1, Elisabeth Limbeck1, Angela Mally1
1Department of Toxicology, University of Würzburg, 97078 Würzburg, Germany.
Abstract:
Furan hepatotoxicity is thought to be linked to covalent binding of its reactive metabolite, cis-2-butene-1,4-dial, to hepatic proteins critical for cell homeostasis and survival. We previously identified 61 putative furan target proteins, which participate in various cellular processes including carbohydrate metabolism, fatty acid β-oxidation, adenosine triphosphate (ATP) synthesis, protein folding and maintenance of redox homeostasis. To further investigate the biological significance of target protein modification, this study was designed to determine the impact of furan on the activity of key target enzymes involved in glycolysis, β-oxidation, ATP synthesis, and redox regulation in rat liver, and to link these functional changes to alterations in cellular processes. While cis-2-butene-1,4-dial inhibited thioredoxin 1 (Txn1) in a cell-free assay, in livers of rats treated with a single high dose of furan Txn1 activity was markedly increased due to rapid up-regulation of Txn1 mRNA expression. Significant inhibition of glyceraldehyde-3-phosphate dehydrogenase and metabolic changes consistent with blocked glycolytic breakdown of glucose were observed in rat liver in response to a single high dose of furan. In contrast, furan treatment resulted in increased activity of enoyl-CoA hydratase and enhanced production of ketone bodies, indicative of increased utilization of fatty acids as energy source. Consistent with changes in TCA cycle metabolites, furan treatment resulted in a reduction of succinate dehydrogenase activity, supporting mitochondrial dysfunction as a critical event in furan toxicity. No significant changes in target protein function were observed following repeated administration of furan at lower dose (0.1 and 0.5mg/kg bw for 4 weeks) closer to estimated human exposure to furan via food. Although the relative contribution of furan mediated alterations in metabolic pathways and antioxidant defense to the overall toxic response to furan, including considerations of dose and time, remains to be established, our work contributes to mapping biological processes and toxicity pathways modulated by reactive electrophiles.
Insights
Furan exposure alters liver enzyme activity and metabolic pathways, impacting cellular functions. High furan doses disrupt glycolysis and mitochondrial function, while lower doses show no significant protein changes.
Area of Science:
- Toxicology
- Biochemistry
- Molecular Biology
Background:
- Furan hepatotoxicity is linked to its reactive metabolite, cis-2-butene-1,4-dial, binding to critical hepatic proteins.
- Previous work identified 61 furan target proteins involved in metabolism, ATP synthesis, protein folding, and redox homeostasis.
Purpose of the Study:
- To investigate the impact of furan on key enzyme activities in rat liver.
- To link functional enzyme changes to alterations in cellular processes and understand furan toxicity pathways.
Main Methods:
- Analysis of enzyme activities (thioredoxin 1, glyceraldehyde-3-phosphate dehydrogenase, enoyl-CoA hydratase, succinate dehydrogenase) in rat liver.
- Measurement of mRNA expression and metabolic products (ketone bodies, TCA cycle metabolites).
- Treatment of rats with single high-dose or repeated low-dose furan.
Main Results:
- High-dose furan increased thioredoxin 1 (Txn1) activity and mRNA, inhibited glyceraldehyde-3-phosphate dehydrogenase, and altered glycolysis.
- Furan treatment enhanced fatty acid utilization (increased enoyl-CoA hydratase activity, ketone body production) but reduced succinate dehydrogenase activity, indicating mitochondrial dysfunction.
- Repeated low-dose furan administration did not cause significant changes in target protein function.
Conclusions:
- Furan disrupts key metabolic pathways and mitochondrial function in the liver, particularly at high doses.
- The study maps biological processes and toxicity pathways affected by furan, highlighting dose and time dependency.
- Further research is needed to establish the contribution of these metabolic alterations to overall furan toxicity.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Drug Metabolism: Phase II Reactions

